Published in Vaccine Weekly, January 17th, 2007
The vaccine strategy combines the use of two technologies. The first technology provides a mechanism to identify conserved portions of the virus that are relevant to the immune system, which can be used to develop a "universal" influenza virus vaccine. The vaccine is designed to induce cellular (T-cell) immune responses and is predicted to be effective against current circulating and novel viral strains, such...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.